MarketInOut Stock Screener Log In | Sign Up
 

Sionna Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/11/2026
Sionna Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization354.43 mln
Float27.87 mln
Earnings Date11/11/2026

1-Year Forecast

20.86
Transformational upside

Relative Strength

99 / 100
Top performer

Debt / Equity

0.03
Debt-free

ROE

-32.06
Deeply negative

ROA

-30.33
Deeply negative

Business Description

Sionna Therapeutics Inc. is a Waltham, Massachusetts-based company founded in 2019 and focused solely on finding better treatments for cystic fibrosis. The company has built a broad pipeline of experimental drugs, several of which have already advanced through early and mid-stage clinical trials. Each drug candidate targets a different part of the protein responsible for cystic fibrosis, with the goal of offering patients more effective options than those currently available.

Key Fundamentals

EPS-2.15
ROE-32.06
ROIC-128
ROA-30.33
EBITDA, mln-108
EV / EBITDA-0.57
EV / EBIT-0.56

Financial Strength

1-Year Target Price20.86
Short Ratio1.01
Short % of Float15.42

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 16.3% 97 / 100   
1 Month 25.6% 96 / 100   
2 Months -79.22% 2 / 100   
6 Months -78.6% 3 / 100   
1 Year -66.55% 10 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us